73 results
SC TO-T
EX-99
INVA
Innoviva Inc
25 Jul 22
Third party tender offer statement
8:34am
% of the outstanding Preferred Shares had agreed in writing to waive all consent and voting rights on behalf of all holders of Preferred Shares with respect
SC TO-C
EX-99.1
INVA
Innoviva Inc
23 May 22
Information about tender offer
8:53pm
No Proxies for, Encumbrances on or Disposition of Shares; Transfer of Voting Rights. During the Support Period, except pursuant to the terms of this Agreement
SC TO-C
EX-99.2
INVA
Innoviva Inc
23 May 22
Information about tender offer
8:53pm
of Voting Rights. During the Support Period, except pursuant to the terms of this Agreement, Stockholder shall not, without the prior written consent
8-K
EX-99.1
iaclxd4y7fhcmjsdp
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-99.2
z7xx7 nytrfg0y9
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-10.5
nyklqo
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
dxk5ei stmr20j
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
424B5
cn0twede3lamsd5yy1dn
18 Jan 13
Prospectus supplement for primary offering
12:00am
S-3ASR
vvc9mrj
16 Jan 13
Automatic shelf registration
12:00am